Concert Pharmaceuticals, Inc.
CNCEDelisted Mar 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367920
Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Concert Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 91 | 79 | −12 |
| Shares | 20.8M | 18.3M | −2.46M (−11.8%) |
| Value | $103.6M | $77.2M | −$26.4M (−25.4%) |
New holders (14)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RBF Capital, LLC | 139,106 | $587.0K | 0.03% |
| Ergoteles LLC | 123,157 | $520.0K | 0.01% |
| Bridgeway Capital Management, LLC | 113,100 | $477.0K | 0.01% |
| HRT Financial LP | 86,083 | $363.0K | 0.00% |
| Tibra Equities Europe Ltd | 82,500 | $348.0K | 0.11% |
| Jump Financial, LLC | 36,533 | $154.0K | 0.01% |
| Black Diamond Financial, LLC | 34,500 | $146.0K | 0.06% |
| Jane Street Group, LLC | 26,404 | $111.0K | 0.00% |
| LMR Partners LLP | 15,752 | $66.0K | 0.00% |
| ExodusPoint Capital Management, LP | 12,772 | $54.0K | 0.00% |
| Group One Trading, L.P. | 3,100 | $13.0K | 0.00% |
| Tarbox Family Office, Inc. | 3,000 | $13.0K | 0.00% |
| Federated Hermes, Inc. | 2,656 | $11.0K | 0.00% |
| Quantbot Technologies LP | 1,034 | $4.00K | 0.00% |
Sold out (26)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.